Agimexpharm Pharmaceutical JSC (AGP) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Agimexpharm Pharmaceutical JSC

Why is Agimexpharm Pharmaceutical JSC ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

11.20%

EBIT Growth (5y)

12.37%

EBIT to Interest (avg)

3.11

Debt to EBITDA (avg)

3.39

Net Debt to Equity (avg)

1.01

Sales to Capital Employed (avg)

1.00

Tax Ratio

19.17%

Dividend Payout Ratio

23.43%

Pledged Shares

Institutional Holding

ROCE (avg)

11.92%

ROE (avg)

11.31%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

4.46

EV to EBITDA

3.30

EV to Capital Employed

0.50

EV to Sales

0.51

PEG Ratio

Dividend Yield

ROCE (Latest)

11.24%

ROE (Latest)

11.23%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bearish

Bollinger Bands

Mildly Bearish

Sideways

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for Agimexpharm Pharmaceutical JSC

Net Sales

Highest at VND 143,576.2 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (VND MM)

Pre-Tax Profit

Highest at VND 12,333.06 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (VND MM)

Net Profit

Highest at VND 10,139.38 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (VND MM)

EPS

Highest at VND 789.97

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (VND)

Raw Material Cost

Fallen by -12.6% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Agimexpharm Pharmaceutical JSC

Interest

At VND 5,900.59 MM has Grown at 14.36%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (VND MM)

Interest Coverage Ratio

Lowest at 303.55

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Interest

Highest at VND 5,900.59 MM

in the last five periods and Increased by 14.36% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (VND MM)

Operating Profit

Lowest at VND 17,911.15 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (VND MM)

Operating Profit Margin

Lowest at 12.48 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales